Clariane Group reports a strengthened financial position six months ahead of schedule, completing a €1.5 billion plan to improve financial health. Revenue in first half of 2025 increased by 4.8% organically. EBITDA pre-IFRS 16 was €263 million, down 4.1% due to pricing structure changes in France. Net debt reduced by €212 million to €3.6 billion.

Successful completion of the plan includes €1 billion in disposals, access to funding back to normal, and a reduction in net debt. Operational performance shows revenue up 4.8% organically. EBITDA pre-IFRS 16 was stable, while net profit decreased. Guidance for 2025 includes expected revenue growth of 5% organically and a reduction in net debt.

Sophie Boissard, CEO, praises completion of the financial strengthening plan ahead of schedule. Long-Term Care business shows good momentum. France experiences challenges due to new pricing structure for healthcare services. Second half expected to benefit from corrective measures and operational adjustments.

Financial performance in the first half of 2025 saw revenue increase by 4.8% organically. EBITDAR pre-IFRS 16 was stable, while EBITDA pre-IFRS 16 decreased. Net result showed a loss of €47 million pre-IFRS 16. Net debt was reduced by €212 million. Guidance for 2025 includes an expected EBITDA growth target of 6-9%.

Clariane Group aims to reduce debt further, improve operational performance, and maintain development investments. The Group confirms its target of reducing the Wholeco financial leverage ratio to below 5.5x by the end of 2025. Non-financial targets include a Net Promoter Score of at least 40 and a reduction in greenhouse gas emissions.

Read more at GlobeNewswire: 2025 Half-Year results